InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

15
Insider
Date
Role
Action
Shares
Price
Amount
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
1,469
$16.20
$23.80K
Houte Hans van
4 Nov 2026
Chief Financial Officer
Sold on a plan
3,300
$15.38
$50.76K
Christine Ring
3 Nov 2026
Chief Legal Officer
Sold on a plan
6,113
$25.83
$157.92K
Houte Hans van
4 Aug 2026
Chief Financial Officer
Sold on a plan
2,967
$24.65
$73.13K
Houte Hans van
4 Aug 2026
Chief Financial Officer
Sold on a plan
1,794
$23.89
$42.86K
Gwenn Hansen
4 Aug 2026
Chief Scientific Officer
Sold on a plan
2,611
$24.64
$64.34K
Gwenn Hansen
4 Aug 2026
Chief Scientific Officer
Sold on a plan
1,500
$23.87
$35.80K
Gwenn Hansen
25 Jun 2026
Chief Scientific Officer
Sold on a plan
5,394
$20.00
$107.88K
Houte Hans van
5 May 2026
Chief Financial Officer
Sold on a plan
582
$17.18
$10.00K
Houte Hans van
5 May 2026
Chief Financial Officer
Sold on a plan
13,473
$16.58
$223.32K
Christine Ring
4 May 2026
Chief Legal Officer
Sold on a plan
8,148
$16.96
$138.21K
Christine Ring
1 May 2026
Chief Legal Officer
Sold on a plan
5,394
$16.76
$90.41K
Christine Ring
2 Apr 2026
Chief Legal Officer
Sold on a plan
8,148
$15.24
$124.15K
Christine Ring
2 Mar 2026
Chief Legal Officer
Sold on a plan
8,148
$15.44
$125.79K
Christine Ring
9 Feb 2026
Chief Legal Officer
Sold on a plan
14,261
$16.66
$237.62K
Show all 49 transactions →

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 33
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 295,015
History held since 29 Jul 2020